08:44 AM EST, 01/07/2025 (MT Newswires) -- Merck ( MRK ) has agreed to acquire the assets of Chinese pharmaceutical company WuXi Biologics' Ireland subsidiary for $500 million, according to a Hong Kong stock exchange filing Monday.
According to WuXi Biologics' filing, its Ireland facility in Dundalk was designed and constructed for Merck ( MRK ) to manufacture commercial vaccines.